Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 19/20 | 1.00 |
| ▸ | TYK2 | P29597 | 8/20 | 1.00 |
| ▸ | JAK3 | P52333 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | JAK2 | O60674 | 6/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22511889 | 1.00 | JAK1 (1.00) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL21419615 | 1.00 | JAK1 (1.00) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL12385674 | 1.00 | JAK1 (1.00) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL14643444 | 0.94 | JAK1 (0.89) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL14605270 | 0.94 | JAK1 (0.89) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL14605271 | 0.94 | JAK1 (0.89) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL14605269 | 0.94 | JAK1 (0.89) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL14643446 | 0.94 | JAK1 (0.89) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL12385607 | 0.93 | JAK1 (0.88) | JAK1TYK2JAK3CYP3A4JAK2 | |
| SCHEMBL2280828 | 0.93 | JAK1 (0.88) | JAK1TYK2JAK3CYP3A4JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013007765-A1 | FUSED TRICYCLIC COMPOUNDS FOR USE AS INHIBITORS OF JANUS KINASES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-01-17 | — | — | WO | disclosed |
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |